Author name: admin

For the third consecutive year, the prestigious AREVIR meeting in Cologne, Germany, welcomed a dedicated session by EuCARE, marking yet another milestone in our collaborative efforts to combat infectious diseases. The session was brimming with lively exchanges of knowledge and innovative ideas, showcasing the remarkable progress achieved by the project across various fronts. Led by […]

We’re thrilled to share that EuCARE will be featured in a special session at the AREVIR Meeting 2024 for the third time! 🎉 Our team has the opportunity to showcase our latest research findings and collaborations in the fight against infectious diseases. From groundbreaking studies to impactful initiatives, EuCARE is committed to making a difference

🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include the Hospitalised cohort, focusing on patients with COVID-19, and the Post-COVID cohort (PASC), investigating long-term sequelae of the virus. Enrollment status for clinical studies 🔬 Unprecedented Progress in Research: EuCARE

EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established in 1993, serves as a vital platform for basic scientists and clinical investigators to exchange insights into the epidemiology and biology of human retroviruses and associated diseases. Pontus Hegberg, a

On January 30, the first meeting of the Coordination Board, a COMECT (Coordination Mechanism for Cohorts and Trials) activity, was held, gathering together the Cohort Coordination Board (CCB) and the Trial Coordination Board (TCB). Representatives of the existing network and infrastructure were present, including the TCB Tx Pillar and the Vaccine Pillar. Among the discussion

This cohort study within the EuCARE project entitled: “In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project”, uses data from 38,585 adult patients hospitalised with SARS-CoV-2 Wild-type, Alpha, Delta, or Omicron infection across 10 centres in 9 countries: Germany, Italy, Kenya, Lithuania, Mexico, Poland, Portugal,

On the past 21st of December 2023, Miłosz Parczewski, EuCARE partner from the Pomeranian Medical University in Poland, was appointed National Consultant for Infectious Diseases by Polish Minister of Health. This achievement is an important recognition of Milosz important clinical and research work on Infectious Diseases and specially in Virology. Miłosz Parczewski received the MD

This new study, with the participation of Anders Sönnerborg and Marcus Buggert, was published in the npj Biofilms and Microbiomes journal, part of the prestigious Nature group. The manuscript entitled “Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV”, investigates the influence of the gut

The EuCARE project was highlighted as an article in an important Italian newspaper, within the scope of a piece entitled: “What are the best actions to take in emergency situations” The article includes interventions from EuCARE members: Prof. Giulia Marchetti, Dr. Francesca Incardona, Prof Sara Gandini and Prof. Pietro Lopalco. Prof Giulia Marchetti underlines the

Giulia Marchetti, from the ASST Santi Paolo e Carlo, one of the EuCARE partners, was invited to give a presentation about the “Update on the physiopathological mechanisms of Long-COVID: The role of viral/antigen persistence and links to possible therapeutic strategies” at EMA-Workshop on generating clinical evidence for treatment and prevention options for Long-COVID and Post-acute